ETF Managers Group’s Adaptive Biotechnologies ADPT Stock Holding History

ETF Managers Group’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$394K	Sell	44,598 -127,788	-74%	-$1.13M	0.01%	503
2022 Q4	$1.32M	Buy	172,386 +130,225	+309%	+$1.01M	0.06%	129
2022 Q3	$300K	Sell	42,161 -2,774	-6%	-$26.1K	0.01%	554
2022 Q2	$369K	Buy	44,935 +1,988	+5%	+$17.5K	0.01%	568
2022 Q1	$596K	Buy	42,947 +293	+0.7%	+$4.61K	0.01%	435
2021 Q4	$1.21M	Sell	42,654 -8,745	-17%	-$268K	0.02%	255
2021 Q3	$1.67M	Buy	51,399 +10,014	+24%	+$362K	0.03%	216
2021 Q2	$1.75M	Sell	41,385 -1,342	-3%	-$52.2K	0.03%	234
2021 Q1	$1.61M	Sell	42,727 -4,281	-9%	-$232K	0.03%	220
2020 Q4	$2.79M	Sell	47,008 -2,606	-5%	-$134K	0.06%	164
2020 Q3	$2.38M	Buy	49,614 +31,659	+176%	+$1.33M	0.08%	151
2020 Q2	$827K	Buy	+17,955	New	+$655K	0.03%	203

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $159M AUM 139.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ETF Managers Group's ADPT Position: Q1 2023 in Review

ETF Managers Group reduced its Adaptive Biotechnologies (ADPT) stake by 74% in Q1 2023, selling an estimated $1.13M and leaving 44,598 shares worth $394K. The position accounts for 0.01% of the portfolio, ranked #503.

ETF Managers Group first reported a position in ADPT in Q2 2020 and has held it in 12 quarters since. The position peaked at $2.79M in Q4 2020. 226 funds tracked by Wall St. Rank hold ADPT as of Q1 2023.

ETF Managers Group held 44,598 shares of Adaptive Biotechnologies worth $394K as of Q1 2023.
ETF Managers Group sold 127,788 Adaptive Biotechnologies shares in Q1 2023, an estimated $1.13M.
Adaptive Biotechnologies made up 0.01% of ETF Managers Group's portfolio in Q1 2023, its #503 holding.
ETF Managers Group first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 12 quarters since.
ETF Managers Group's Adaptive Biotechnologies position peaked at $2.79M in Q4 2020.
226 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.